Niveau de preuve du suivi thérapeutique pharmacologique des aminosides
Therapie, 66 1 (2011) 39-44
Published online: 2011-04-07
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Pharmacogénétique de l’ototoxicité des aminosides : état des connaissances et des pratiques – recommandations du Réseau francophone de pharmacogénétique (RNPGx)
Louis Lebreton, Benjamin Hennart, Sarah Baklouti, Aurélien Trimouille, Jean-Christophe Boyer, Laurent Becquemont, Claire-Marie Dhaenens and Nicolas PicardTherapies 79 (6) 709 (2024)
https://doi.org/10.1016/j.therap.2024.05.006
197 (2024)
https://doi.org/10.1016/B978-0-443-18649-3.00017-3
An international survey on aminoglycoside practices in critically ill patients: the AMINO III study
Claire Roger, Benjamin Louart, Loubna Elotmani, et al.Annals of Intensive Care 11 (1) (2021)
https://doi.org/10.1186/s13613-021-00834-4
Evaluation of the clinical practice of aminoglycoside use in paediatric patients in Kenya: findings and implications for lower-middle income countries
Elias Joseph Onyango, Faith Okalebo, Margaret Oluka, et al.JAC-Antimicrobial Resistance 2 (1) (2020)
https://doi.org/10.1093/jacamr/dlz087
Interest of therapeutic drug monitoring of aminoglycosides administered by a monodose regimen
Haifa Ben Romdhane, Nadia Ben Fredj, Amel Chaabane, et al.Néphrologie & Thérapeutique 15 (2) 110 (2019)
https://doi.org/10.1016/j.nephro.2018.08.004
Is Computer-Assisted Aminoglycoside Dosing Managed by a Pharmacist a Safety Tool of Pharmacotherapy?
E. DVOŘÁČKOVÁ, P. PÁVEK, B. KOVÁČOVÁ, et al.Physiological Research S87 (2019)
https://doi.org/10.33549/physiolres.934329
Determinants of amikacin first peak concentration in critically ill patients
Clément Boidin, Sophie Jenck, Laurent Bourguignon, Sejad Torkmani, Aurore Roussey‐Jean, Stanislas Ledochowski, Lucie Marry, Nacim Ammenouche, Hervé Dupont, Frédéric Marçon, Bernard Allaouchiche, Julien Bohé, Alain Lepape, Sylvain Goutelle and Arnaud FriggeriFundamental & Clinical Pharmacology 32 (6) 669 (2018)
https://doi.org/10.1111/fcp.12374
Pharmacologie des Anti-Infectieux
Damien MontangePharmacologie des Anti-Infectieux 57 (2018)
https://doi.org/10.1016/B978-2-294-75300-8.00005-7
Concentrations systémiques d’antibiotiques potentiellement toxiques après administration par pansement imprégné chez un patient brûlé : à propos d’un cas clinique
Julien Dupouey, Sandrine Wiramus, Jacques Albanese, Romain Guilhaumou and Olivier BlinTherapies 71 (5) 483 (2016)
https://doi.org/10.1016/j.therap.2016.03.001
Suivi thérapeutique pharmacologique des aminosides : amikacine, gentamicine, tobramycine
L. Bourguignon, Y. Cazaubon, S. Goutelle and J. GuittonEMC - Biologie Médicale 11 (2) 1 (2016)
https://doi.org/10.1016/S2211-9698(15)61318-8